Skip to main content
. Author manuscript; available in PMC: 2010 May 10.
Published in final edited form as: Gastroenterology. 2008 Sep 4;135(4):1079–1099. doi: 10.1053/j.gastro.2008.07.076

Table 2.

Some Targeted Genes in MMR-Deficient (or MSI) Colorectal Cancers and Their Reported Mutation Frequency

Gene Chromosome Microsatellite tract MSI colorectal cancer mutation frequency (%) Normal function
TGFBR2 3p22 A10 90 TGF-β signaling
ACVR2 2q22-23 A8 and A8 86 Activin signaling
IGFIIR 6q26-27 G8 10 Insulin-like growth factor and TGF-β signaling
BAX 19q13.3-q13.4 G8 50 Apoptosis
hMSH3 5q11-q12 A8 50 DNA MMR
hMSH6 2p16 C8 33 DNA MMR
E2F-4 16q21-q22 (CAG)13 65 Cell cycle control
PTEN 10q23.3 A6 and A6 19–34 Growth regulation
MBD4 (MED1) 3q21-q22 A10 40 DNA repair and binding to methylated DNA
TCF4 10q25.3 A9 39 Growth regulation
CHK1 11q22-q23 A9 10 G2 cell cycle checkpoint
STK11 (LKB1) 19p13.3 C6 <2 Signal transduction
BLM 15q26.1 A9 <18 Chromosome stability/DNA repair; helicase
Caspase-5 (ICErel-III) 11q22.2-22.3 A10 62 Apoptosis
CDX2 13q12.3 C6 and G6 <2 Homeobox protein
TBP 6q27 (CAG)19 and (CAG)16 83 TATA binding protein
RIZ 1p36 A8 and A9 26 Interacts with RB
hRAD50 5q31 A9 and A8 31 DNA repair
SEC63 6q21 A10 49 ER chaperone protein
AIM2 1q22 A10 48 Interferon-inducible protein